semaglutide effects on thyroid contraindications glp-1 GLP-1 analogs (option B), also known as GLP-1 receptor agonists (e.g., liraglutide, semaglutide, dulaglutide), are contraindicated in patients with a personal or family history of medullary thyroid hypothyroidism and semaglutide with Underactive

Wegovy is administered once weekly via subcutaneous injection, with doses gradually increased over time (0.25 mg 0.5 mg 1.0 mg 1.7 mg 2.4 mg) to minimise gastrointestinal side effects

Weight Loss Treatment Built Around You Complete a short intake assessment to see if prescription weight-loss treatment is right for you, and get guidance on next steps tailored to your health history

The STEP trials have consistently demonstrated Wegovys efficacy across different patient populations, including those with and without diabetes

At Skintellect Laser & Aesthetics , we offer both Semaglutide and Tirzepatide as part of our weight loss treatmen t options